Immutep raises $68m to fund cancer trials until 2026
SYDNEY: Immutep, an immunotherapy-focused biotech, has raised $68m from institutional investors to fund clinical trials
SYDNEY: Immutep, an immunotherapy-focused biotech, has raised $68m from institutional investors to fund clinical trials
FEATURED
Nursing home plans approved for site of elderly housing
Thousands of elderly people evicted from care homes every year
New proposal to convert ageing hotel into elderly housing
Technology to be embedded in multigenerational community within university
Aged care provider introduces on-the-job microlearning stations
Transforming public health through social innovation
INNOVATION
